Paul Hartmann AG (PHH2.F)
Frankfurt · EUR · Healthcare · Medical Instruments & Supplies
€192.00 (-0.52%) as of
Key statistics
- Market cap
- 681.93M
- P/E (TTM)
- 6.71
- EPS (TTM)
- 28.63
- Dividend yield
- 4.22%
- 52-week range
- 187.50 – 235.00
- Beta
- 0.49
- Revenue (TTM)
- 2.49B
- Profit margin
- 4.02%
- Volume
- 50.00
About Paul Hartmann AG
Paul Hartmann AG manufactures and sells medical and care products in Germany, the rest of Europe, the Middle East, Africa, Asia and Pacific region, and the Americas. The company operates through three segments: Wound Care, Incontinence Management, and Infection Management. It offers absorbent underwear, incontinence pads and pants, and fixation pants; medical skincare products; wound management products, such as hydro active wound and silicone SAP dressings, post-op dressings, nature care, adhesive fixation, non-adhesive fixation, gauze, sponges/tamponades, contact layers, absorption pads, cotton, and negative pressure wound therapy; compression, universal, zinc paste, and padding bandages; and hands, skin, surface, instruments, and equipment disinfection and hygiene products. In addition, the company sells operating theater products, including surgical drapes, operating theater clothing, surgical gloves, surgical absorbents and instruments; various Mediset products; patient care products, such as hygiene and maternity products, examination gloves, and nursing care products; diagnostics, such as blood pressure monitors, scale, and thermometers; first aid products; and cotton wool and cosmetic products. It sells its products under the CombiSet, DermaPlast, MoliCare, Sterillium, Veroval, and Zetuvit brands. Paul Hartmann AG was founded in 1818 and is headquartered in Heidenheim, Germany.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Headquarters
- Heidenheim, Germany
- Employees
- 9,881
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.